Reindert Graaff
Overview
Explore the profile of Reindert Graaff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
1064
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Boersma H, van Waateringe R, van der Klauw M, Graaff R, Paterson A, Smit A, et al.
BMC Endocr Disord
. 2021 Jan;
21(1):14.
PMID: 33435948
Background: Skin autofluorescence (SAF) is a non-invasive marker of tissue accumulation of advanced glycation endproducts (AGE). Recently, we demonstrated in the general population that elevated SAF levels predict the development...
3.
van Waateringe R, Fokkens B, Slagter S, van der Klauw M, van Vliet-Ostaptchouk J, Graaff R, et al.
Diabetologia
. 2018 Nov;
62(2):269-280.
PMID: 30460578
Aims/hypothesis: Earlier studies have shown that skin autofluorescence measured with an AGE reader estimates the accumulation of AGEs in the skin, which increases with ageing and is associated with the...
4.
Ramsauer B, Graaff R, Sikole A, Trajceska L, Lundstrom S, Arsov S, et al.
Artif Organs
. 2018 Sep;
43(2):173-180.
PMID: 30229953
Tissue advanced glycation end products (AGEs) are a measure of cumulative metabolic and oxidative stress and cytokine-driven inflammatory reactions. AGEs are thought to contribute to the cardiovascular complications of hemodialysis...
5.
van Waateringe R, Mook-Kanamori M, Slagter S, van der Klauw M, van Vliet-Ostaptchouk J, Graaff R, et al.
PLoS One
. 2017 Jun;
12(6):e0179330.
PMID: 28632785
Background: Skin autofluorescence, a biomarker for advanced glycation end products (AGEs) accumulation, has been shown to predict diabetes-related cardiovascular complications and is associated with several environmental and lifestyle factors. In...
6.
van Waateringe R, Slagter S, van Beek A, van der Klauw M, van Vliet-Ostaptchouk J, Graaff R, et al.
Diabetol Metab Syndr
. 2017 Jun;
9:42.
PMID: 28572855
Background: The metabolic syndrome (MetS) comprises several cardiometabolic risk factors associated with increased risk for both type 2 diabetes and cardiovascular disease. Skin autofluorescence (SAF), a non-invasive biomarker of advanced...
7.
Ramsauer B, Engels G, Graaff R, Sikole A, Arsov S, Stegmayr B
BMC Nephrol
. 2017 Jan;
18(1):5.
PMID: 28056864
Background: Haemodialysis (HD) patients suffer from an increased risk of cardiovascular disease (CVD). Skin autofluorescence (SAF) is a strong marker for CVD. SAF indirectly measures tissue advanced glycation end products...
8.
Sprenger H, Bierman W, Martes M, Graaff R, van der Werf T, Smit A
AIDS
. 2016 Oct;
31(2):241-246.
PMID: 27763891
Objective: HIV-1 infection is associated with an increased cardiovascular disease (CVD) risk. Advanced glycation end products are formed as stable markers of glycaemic and oxidative stress. Skin autofluorescence (SAF) as...
9.
van Waateringe R, Slagter S, van der Klauw M, van Vliet-Ostaptchouk J, Graaff R, Paterson A, et al.
Eur J Clin Invest
. 2016 Mar;
46(5):481-90.
PMID: 27002914
Background: Skin autofluorescence (SAF) is a noninvasive marker of advanced glycation end products (AGEs). In diabetes, higher SAF levels have been positively associated with long-term complications, cardiovascular morbidity and mortality....
10.
Ramsauer B, Engels G, Arsov S, Hadimeri H, Sikole A, Graaff R, et al.
Int J Artif Organs
. 2015 Oct;
38(9):488-93.
PMID: 26481293
Background: Tissue advanced glycation end products (AGE) are increased in hemodialysis (HD) patients, especially those with cardiovascular complications. Skin autofluorescence (skin-AF) can noninvasively estimate the accumulation of AGE in tissue....